Accuray (ARAY) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/06/25
Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises GuidancePRNewsWire • 02/05/25
Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture ProductPRNewsWire • 01/23/25
Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025PRNewsWire • 01/22/25
Accuray (ARAY) Shows Fast-paced Momentum But Is Still a Bargain StockZacks Investment Research • 01/20/25
ARAY Stock Gains as China Approves Latest Radiation Therapy SolutionsZacks Investment Research • 01/14/25
Accuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and CyberKnife® S7™ Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo® C SystemPRNewsWire • 01/13/25
Here Is Why Bargain Hunters Would Love Fast-paced Mover Accuray (ARAY)Zacks Investment Research • 01/03/25
ARAY Stock Falls Despite Positive Data of CyberKnife in Treating BSMZacks Investment Research • 12/19/24
New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to TreatPRNewsWire • 12/18/24
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Accuray (ARAY)Zacks Investment Research • 12/16/24
Accuray Q1 Earnings Meet Estimates, Sales Beat, Gross Margin ShrinksZacks Investment Research • 11/07/24
Accuray (ARAY) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 11/07/24
Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024PRNewsWire • 10/23/24